Breast cancer rates fell with hormone therapy drop

	Tweet

Breast cancer rates among postmenopausal women in Canada dropped nearly 10 percent after news of a big study in 2002 that found taking hormone replacement therapy could increase breast cancer risk, researchers said on Thursday.

The decline coincided with a sharp decline in use of the drugs after publication of the Women’s Health Initiative study, which found an increased risk of ovarian cancer, breast cancer, strokes and other problems from hormone therapy.

Before 2002, doctors widely prescribed hormone replacement therapy, or HRT, to lower the risk of heart disease or osteoporosis, both of which go up sharply after menopause.

Sales of U.S. market leader Wyeth’s combined estrogen-progestin therapy Prempro have fallen by about 50 percent since 2001 to around $1 billion a year. Wyeth is now owned by Pfizer.

To see if the drop in use affected breast cancer rates, Prithwish De of the Canadian Cancer Society and colleagues analyzed data from various Canadian registries and from a national health survey of women aged 50-69.

They specifically scanned for prescriptions on hormone replacement therapy, breast cancer incidence, mammography rates and women’s self-reported use of hormone replacement therapy.

They found in 2002 that 12.7 percent of Canadian women aged 50-69 used HRT but this fell to 4.9 percent of these women by 2004. During the same period, breast cancer rates fell 9.6 percent, but mammogram rates remained stable.

They said the drop was likely linked to media coverage about the Women’s Health Initiative study and a British study released around the same time known as the Million Women Study - both of which showed increases in breast cancer risk in women who used hormone replacement therapy.

In 2005, breast cancer rates in Canada began to creep back up among women aged 50 to 69. That rebound may mean that hormone replacement therapy speeds the growth of hidden breast cancers, but does not cause them, the team reported in the Journal of the National Cancer Institute.

About 75 percent of breast cancers are estrogen-receptor positive, meaning they are fed by estrogen.

The study was limited because it was based on data women reported themselves, and it did not include data on how often or how long they were treated, the team said. They said more long-term studies might help clarify the link.

Doctors now recommend hormone replacement therapy for women suffering severe menopause symptoms, but caution that they should use the lowest dose possible for the shortest period of time.

More than 400,000 women die from breast cancer globally each year.

SOURCE:  Journal of the National Cancer Institute, published online September 23, 2010.

RELATED STORIES:
New Peptide Could be Effective Treatment for Triple Negative Breast Cancer   New Guideline Will Improve Hormone Receptor Testing for Patients with Breast Cancer   Breast cancer survivors at higher risk for falls   Emerging research heralds new era of breast cancer management   New national poll: 89 percent of women said mammograms vital to their health   New Study Finds Usual Care Enough to Promote the Well Adjustment to Early Breast Cancer   New Way of Expanding Cancer Screening for Minority Women   Breast Cancer Incidence Among Iraqi Women Profiled   Prototype Breast Cancer Imaging System May Improve Patient Care   Plastic Surgeons Offer Microsurgery Technique for Breast Reconstruction, Tummy Tuck After Mastectomy   MSU study finds media coverage of breast cancer focuses too little on prevention   Ovarian cysts linked to lower breast cancer risk   Researchers suggest new paradigm for breast cancer screening   Study sheds light on breast cancer drug failure   Breast cancer study says more than 1,700 black women die unnecessarily each year   Some women worry too much about breast cancer returning, U-M study finds   Scientists developing breast cancer treatment test news   Mammography screening reduced risk for death from breast cancer by half   Pregnancy cuts breast cancer in mutation carriers   Breast Cancer Tumors Grow Faster In Younger Women   Fish oil may cut breast cancer risk ‘by a third’   Fertility procedures need not delay breast cancer treatment for younger women

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]